Text size Data from BioNTech and Pfizer were particularly promising. Jeenah Moon / Getty Images After a hiatus from a late summer break, the news of a Covid-19 vaccine is heating up again as a handful of leading programs are rapidly moving to a decisive phase. Reports from several companies …
Read More »CureVac and EU in advanced talks for 225 million doses of Covid-19 vaccine
Shares of CureVac NV rose Thursday after the German biotech company said it was in advanced talks to deliver at least 225 million doses of a potential Covid-19 vaccine to EU member states. CureVac said talks with the EC, the executive arm of the European Union, include an option to …
Read More »Alibaba earnings analysts have cheered ‘V-shaped recovery’, but stock falls
Alibaba Group Holding Ltd. said most of its companies are now back to “healthy growth” as China recovers from the COVID-19 crisis. The Chinese e-commerce giant topped revenue and revenue expectations with its fiscal report in the first quarter beginning Thursday, although its shares were 1.6% off in midday trading. …
Read More »For Covid-19 vaccine, J&J plans 60,000 subject pivotal trial
Johnson & Johnson plans to launch in late September what may be the largest clinical trial to date against a coronavirus vaccine, enrolling up to 60,000 people worldwide to test whether the experimental shot safely protects against Covid-19. The targeted enrollment, reported on a government database and confirmed by the …
Read More »Target sales are jumping as pandemic speed e-commerce shift
The coronavirus pandemic has widened the gap between winners and losers of retail, increasing the capacity of large U.S. chains that could remain open throughout the pandemic and feed America’s basic needs. The evidence was strong this week when nationwide retailers revealed they were heading out the summer months in …
Read More »